Published in Medicine and Law Weekly, December 16th, 2005
Under the terms of the agreement, Compex will become a subsidiary of Encore and Encore will issue approximately 1.4 shares of its common stock for each share of common stock of Compex, subject to adjustment as set forth in the agreement. The merger, which has been approved unanimously by the boards of directors of both companies, is subject to the satisfaction of a number of standard closing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly